Home / Recalls / RXQ Compounding LLC / D-1686-2019

D-1686-2019 Class II Terminated

Recalled by RXQ Compounding LLC — Athens, OH

Recall Details

Product Type
Drugs
Report Date
August 14, 2019
Initiation Date
June 19, 2019
Termination Date
September 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide USA

Code Information

All lots within expiry

Other recalls by RXQ Compounding LLC

  • D-1653-2019 Class II — EDETATE DISODIUM 15% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West Stat (June 19, 2019)
  • D-1710-2019 Class II — THIAMINE HCL 100MG/ML (MDV) INJECTION, 10 ML per Vial, RXQ Compounding, 340 West (June 19, 2019)
  • D-1684-2019 Class II — MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State (June 19, 2019)
  • D-1661-2019 Class II — FOLIC ACID 5MG/ML INJECTION SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 (June 19, 2019)
  • D-1636-2019 Class II — Ascorbic Acid 500 MG/ML (Non-Corn) INJ (MDV), 50 mL per vial, RXQ Compounding, 3 (June 19, 2019)
  • D-1646-2019 Class II — DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding (June 19, 2019)
  • D-1687-2019 Class II — MOXIFLOXACIN 0.5% OPHTH SOLUTION SYRINGE, 1 ML per syringe, RXQ Compounding, 340 (June 19, 2019)
  • D-1689-2019 Class II — NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Uni (June 19, 2019)
  • D-1681-2019 Class II — MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compound (June 19, 2019)
  • D-1676-2019 Class II — MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compoun (June 19, 2019)